1+ week, 17+ hour ago  (15+ words) The Future of GLP-1s: Why Dermatologists Should Lead the Charge in Systemic Health'Dermatology Times...

1+ week, 1+ day ago  (107+ words) In his Therapeutic Hotline session at AAD 2026, Darrell Rigel, MD, MS, noted that advances in systemic therapies have transformed outcomes in advanced melanoma, with approximately half of patients achieving long-term survival of 8 to 10 years, particularly with combination regimens. He believes…...

1+ week, 3+ day ago  (108+ words) New 4-year extension data from the PIONEER trial confirm that avapritinib delivers durable, long-term benefit for patients with indolent systemic mastocytosis. At AAD 2026, Lauren Madigan, MD, breaks down what the open-label extension data mean for clinical practice, as dermatology clinicians…...

1+ week, 3+ day ago  (518+ words) Dermatology Times At the 2026 American Academy of Dermatology (AAD) Annual Meeting, Lauren Madigan, MD, associate professor of dermatology at the University of Utah and faculty at the Mastocytosis Center of Excellence at the Huntsman Cancer Institute, presented open-label extension data…...

2+ week, 1+ day ago  (319+ words) Steven Daveluy, MD, reviews long-term trial data for bimekizumab in psoriasis and hidradenitis suppurativa presented at the 2026 AAD Annual Meeting. Long-term data for bimekizumab (Bimzelx; UCB) continue to show sustained efficacy in both psoriasis and hidradenitis suppurativa (HS), with no…...

2+ week, 2+ day ago  (285+ words) Daniel C. Butler, MD, discusses the underrepresentation of older adults in dermatology trials and what a 3-system framework for itch means for clinical practice Butler's entry into itch research came through his broader interest in aging. The immune system, the nervous…...

2+ week, 3+ day ago  (421+ words) Dermatology Times Late-breaking data presented at the 2026 American Academy of Dermatology Annual Meeting highlighted a novel intersection between metabolic modulation and immune-targeted therapy in psoriatic disease. 1 In an on-site discussion, Christopher Bunick, MD, Ph D, associate professor of dermatology at…...

2+ week, 4+ day ago  (530+ words) Dermatology Times Allergic contact dermatitis in children is more common than many clinicians may realize and missing the diagnosis carries real consequences for young patients, Jeff Yu, MD, told Dermatology Times at the 2026 American Academy of Dermatology Annual Meeting. Yu's…...

2+ week, 6+ day ago  (191+ words) At AAD 2026, Melinda Gooderham, MSc, MD, FRCPC, reviewed late-breaking zasocitinib data for psoriasis, noting that 70% of patients reached s PGA 0/1. "We finally will have a pill that can offer the same efficacy as a biologic, and that will open up…...

2+ week, 6+ day ago  (201+ words) Phase 3 data presented at AAD 2026 show once-daily oral therapy clears skin as early as week 4, offering a fast-acting option for patients. Current treatment paradigms for plaque psoriasis, the most prevalent form of psoriasis, often rely on injectable biologics targeting the…...